Shortly before becoming involved in the process of implantation into the uterine wall, mammalian embryos reach the blastocyst stage. Two distinct cell lineages, the trophectoderm (TE) and the inner cell mass (ICM) are already present in these embryos.
bryos to various anomalies in their development after implantation [2±3] . Furthermore, some experiments have shown that ICM cells are more susceptible than TE cells to the direct cytotoxicity of hyperglycaemia [4±6] . Induction of apoptosis was found to occur predominantly in the ICM of rat blastocysts when exposed to hyperglycaemia in utero [4] or to high d-glucose in vitro [7] , raising the hypothesis that an excess loss of crucial pre-fetal stem cells from the ICM lineage could be a key determinant of the early embryopathy associated with pre-conceptional diabetes [8] .
Although little is known about the nature of the interactions between ICM and TE cells, evidence suggests that close cell contact is required between the two cell lineages to ensure the proper development of the implanting blastocyst [1] . Studies of ICM-TE interactions indicate that potent regulatory signals such as fibroblast growth factors (FGFs) could be produced by ICM cells and participate in the control of TE growth by paracrine or juxtacrine mechanisms [9] . The FGF-4 is thought to be one of these major candidate signals because this growth factor has been shown to be preferentially produced in the ICM cells of mouse blastocysts and to help maintain mouse TE cells in an undifferentiated state and proliferative mode [10, 11] .
The observation that ICM cells are highly sensitive to the cytotoxicity of hyperglycaemia and the possible dependence on ICM-derived signals for normal TE development suggests that TE cells could be indirectly affected by a disruption in ICM-to-TE cell signalling. Previous experiments and our data suggest that TE cells and early trophoblasts of mouse and rat blastocysts display signs of abnormal growth following blastocyst exposure to hyperglycaemia [5, 12±14] .
In our study, mouse blastocysts were exposed to different concentrations of d-glucose during 24 h and then analysed for their ability to attach and spread over a fibronectin-coated culture substrate. The expression of FGF-4 in the ICM of these embryos was estimated and the benefit of adding human recombinant FGF-4 to the high d-glucose treatment was also investigated.
Materials and methods
Embryo collection and culture. All investigations were done in accordance with the Guide for Care and Use of Laboratory Animals (National Academy of Science, 1996). Six-week-old female mice from the NMRI strain (University Animal House, Brussels, Belgium) were mated overnight with males from the B 6 D 2 F 1 mouse strain (Iffa Credo, L'Arbresle, France). The presence of a vaginal plug was designated as day 1 of pregnancy. Early blastocysts were recovered on day 4 by flushing the uterine horns with pre-warmed Earle's Balanced Salt Solution (EBSS, Life Technologies, Parsley, UK) culture medium supplemented with 1 mmol/l glutamate, 1 mmol/l pyruvic acid, 0.3 % BSA, 100 U/ml penicillin and 100 mg/ml streptomycin. Blastocysts from different female mice were pooled before random assignment to different culture groups.
Pre-implantation analysis. Early blastocysts were cultured for 24 h in the EBSS-based culture medium with either 6 mmol/l or 28 mmol/l d-glucose. A combination of 22 mmol/l l-glucose and 6 mmol/l d-glucose served as control culture medium for the absence of hyperosmotic effect. At the end of the 24-h incubation period, the blastocysts were examined for different developmental parameters. During the culture period, the blastocoelic cavity of the early blastocyst expands and causes the zona pellucida to become thinner thus allowing the embryo to expand and ultimately hatch from this protective covering. Morphological distribution to either expanded blastocyst or more advanced hatched blastocyst was determined after observation on an inverted phase-contrast microscope. Blastocysts were analysed for the total number of cells per embryo [15] . Between 60 and 100 embryos were examined for each culture group in six independent experiments. Cells with signs of nuclear fragmentation (karyorhexis index) were also counted in the ICM and TE cell populations of around 30 blastocysts for each group in three independent experiments [16] . The three different groups of blastocysts were designated by the following abbreviations according to the composition of the culture medium in which they had been incubated: 6 mmol/l, 28 mmol/l and 22 + 6 mmol/l.
Peri-implantation analysis. Blastocysts were first incubated for 24 h in either 6 mmol/l, 17 mmol/l, 28 mmol/l d-glucose or in the hyperosmotic control culture medium and then transferred into fibronectin-coated culture wells (Bovine plasma fibronectin from Life Technologies, Parsley, UK). Fibronectin was chosen for the study of blastocyst outgrowth because it is a component of the basement membrane of the endometrium and interstitial matrix of the uterine stroma and also because increased fibronectin synthesis accompanies extra-cellular matrix (ECM) remodelling within the uterine endometrium in preparation for implantation [17] . It has been shown to promote the attachment of mouse blastocysts and outgrowth of the trophoblast cells in vitro [18] . Several receptors of the integrin family are expressed by the mouse blastocyst which recognize a specific site of fibronectin and their interaction is supposed to mediate trophoblast cell migration [19] . Other ECM molecules (specially, laminin) are found in the endometrium and have been used as in vitro substrates for studies of blastocyst outgrowth. However, no differences were detected in vitro between laminin and fibronectin in their capacity to promote the attachment and spreading of the mouse blastocyst during this peri-implantation period [18] .
In vitro incubation was then continued for another 48 h in CMRL 1066-based culture medium (Life Technologies, Parsley, UK) containing 6 mmol/l d-glucose, 10 % fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin [20] . Under these culture conditions, blastocysts attach to the culture substrate and their TE cells start to transform into trophoblasts. Blastocyst spreading leads to the formation of a trophoblast outgrowth featuring a central ICM core surrounded by diploid trophoblasts and a fringe of peripheral giant trophoblasts. At the end of the second incubation period, the embryos were examined for their morphological distribution between unattached hatched blastocysts or trophoblast outgrowths. The surface of each trophoblast outgrowth was measured [14] . Between 30 and 50 blastocysts for each experimental group were examined in five independent experiments. The four different groups of embryos were designated by the following abbreviations according to the composition of the culture medium in which they had been incubated during the first 24-h incubation period: p-6 mmol/l, p-17 mmol/l, p-28 mmol/l and p-22 + 6 mmol/l.
FGF-4 protein expression.
Blastocysts were analysed by immunocytochemistry for the expression of FGF-4 at the end of the first incubation period in either 6 mmol/l or 28 mmol/l d-glucose or at the end of the second incubation period after being transferred into fibronectin-coated culture wells. Blastocysts observed at the end of the first incubation period were denuded from their zona pellucida by means of a short treatment in a Tyrode acid solution and then immobilized on concanavalin A-coated coverslips [21] . Adherent trophoblast outgrowths observed at the end of the second incubation period were directly processed for immunocytochemistry. Embryos were fixed with 1.7 % paraformaldehyde in PBS for 30 min at 37 C and then permeabilized for 10 min in 1 % Triton in PBS at room temperature. Incubation with a primary goat anti-human FGF-4 antibody (final concentration of 0.5 mg/ml; Santa Cruz Biotechnology, Santa Cruz, Calif., USA) was done overnight at 4 C in PBS supplemented with 1 % Tween-20 (PBS-T) and 3 % BSA. Embryos were washed in PBS-T and then exposed for 1 h at 37 C to a FITC-conjugated secondary rabbit antigoat IgG antibody (final concentration of 1.7 mg/ml; Vector Laboratories, Burlingame, Calif., USA) in PBS-T and 3 % BSA. Embryos were finally counter-stained with 10 mmol/l TOPRO-3 iodide fluorochrome (Molecular Probes, Leiden, The Netherlands). Negative immunostaining control experiments included the substitution of the primary antibody with normal goat IgG, its omission from the procedure or the omission of both primary and secondary antibodies (autofluorescence control) from the procedure. Immunostained embryos were observed using confocal laser scanning microscopy under a krypton and argon mixed gas laser fitted for the excitation of FITC (488 nm) and Texas Red (568 nm). The entire embryos were reconstituted by the projection of the serial sections acquired along the Z-axis. The FGF-4 protein expression in a blastocyst was measured from the intensity of the immunofluorescence staining in each digital section that had been acquired across the embryo. Measurement of FGF-4 immunostaining intensity was carried out in a similar way in trophoblast outgrowths except that the ICM core only of each embryo was assessed (FGF-4 expression is extremely low in trophoblast cells [22] ). The FGF-4 protein contents were expressed in arbitrary intensity units for each blastocyst or for each ICM core and the results were corrected for variations in corresponding background staining and section areas. At least 10 embryos for each culture group were analysed in 3 independent experiments. The different groups of embryos were designated by the abbreviations 6 mmol/l and 28 mmol/l or p-6 mmol/l, p-28 mmol/l and p-22 + 6 mmol/l according to the composition of the culture medium in which they had been incubated during the first incubation period.
Impact of recombinant FGF-4. Blastocysts were incubated in either 6 mmol/l or 28 mmol/l d-glucose in the presence or absence of 2.5 ng/ml human recombinant FGF-4 (R&D Systems, Minneapolis, Minn., USA) in the presence of 1 mg/ml heparin for 24 h. The embryos were then transferred into fibronectincoated culture wells and incubated for another 48 h with 6 mmol/l d-glucose and no recombinant FGF-4. At the end of this second incubation period, the outgrowths were analysed for different developmental parameters. In addition to assessing their morphology and measuring their trophoblast outgrowth surface, embryos were also fixed and stained in 10 mmol/l TOPRO-3 iodide (Molecular Probes, Leiden, The Netherlands) for 15 min and then the number of trophoblasts detected around the central ICM core were counted. The average trophoblast nuclear area and the percentage of trophoblasts showing signs of karyorhexis were also measured in each embryo. Giant trophoblasts were identified on the basis of a previously published linear relation between trophoblast nuclear area and trophoblast nuclear DNA content [23] . Trophoblasts with a nuclear DNA content higher than 6 n were counted as giant cells and their percentage (giant nucleus index) was determined in each trophoblast outgrowth. Between 12 and 22 embryos for each culture group were examined in three independent experiments. The different groups of embryos were designated by the abbreviations p-6 mol/l, p-6 mmol/l + FGF-4, p-28 mmol/l and p-28 mmol/l + FGF-4 according to the composition of the culture medium in which they had been incubated during the first incubation period. Blastocysts were also incubated during the first incubation period in 22 mmol/l l-glucose + 6 mmol/l d-glucose containing culture medium (p-22 + 6 mmol/l).
Statistical analysis. Morphological distributions were expressed as percentages and compared by Chi-square (c 2 ) analysis. Average numbers of cells for each blastocyst and each trophoblast outgrowth, average trophoblast outgrowth surfaces and average trophoblast nuclear areas were given as Means SEM values and compared by one-way analysis of variance coupled to post hoc Fisher's test. Percentages (indexes) of cells featuring signs of karyorhexis and percentages of trophoblasts transformed into giant cells were compared by means of nonparametric analysis Kruskal-Wallis. The FGF-4 protein expression data were tested for normal distribution and then compared using the Student's unpaired t test in blastocysts cultured 24 h in 6 mmol/l and 28 mmol/l d-glucose. In trophoblast outgrowths pre-exposed to different combination of glucose, FGF-4 protein expression was compared by one-way analysis of variance coupled to post-hoc Fisher's test. A p value of less than 0.05 was considered to be statistically significant.
Results
When mouse blastocysts were incubated for 24 h in either 6 mmol/l or 28 mmol/l d-glucose, no difference was found between the two culture groups with respect to the percentage of blastocysts that had hatched from the zona pellucida at the end of the incubation period (p = 0.35) (Fig. 1A) . However, blastocysts exposed to 28 mmol/l d-glucose showed a decrease in the total number of cells for each embryo (p £ 0.05) (Fig. 1B) . Close examination of differentially stained blastocysts detected a 57 % increase in the proportion of ICM cells showing signs of karyorhexis following exposure to 28 mmol/l d-glucose (Fig. 1C) . However this increase was not statistically significant (p = 0.26). The incidence of this apoptotic nuclear event remained very low and did not changed in the TE cell lineage. None of the developmental markers analysed above were modified when blastocysts were cultured in a combination of 22 mmol/l l-glucose and 6 mmol/l d-glucose.
In a second series of experiments, blastocysts preincubated 24 h in increasing concentrations of d-glucose and then further cultured 48 h in 6 mmol/l d-glu-cose, showed no significant difference with respect to the proportion of blastocysts that had attached and spread over the culture substrate (p = 0.07) (Fig. 1D) . Measurement of the total surface of the trophoblast outgrowths showed, however, that pretreating embryos with 17 mmol/l or 28 mmol/l d-glucose resulted in a statistically significant 18 % increase in the spreading of their trophoblasts (p £ 0.05) (Fig. 1E) . When pre-treated with 17 mmol/ l d-glucose for 24 h before transfer into fibronectincoated culture wells, embryos from another female mouse strain (OF1) mated to B 6 D 2 F 1 males showed a 27 % increase in their trophoblast outgrowth surface compared with control embryos (data not shown). None of the developmental parameters analysed above were influenced by pre-exposing embryos to a combination of 22 mmol/l l-glucose and 6 mmol/l d-glucose during the first incubation period.
FGF-4 expression was observed in mouse blastocysts exposed to 6 or 28 mmol/l d-glucose for 24 h and after another 48 h in 6 mmol/l d-glucose when a trophoblast outgrowth was formed. In accordance with previous reports, FGF-4 immunostaining was detected predominantly in the ICM of hatched blastocysts and completely restricted to the ICM core after trophoblast outgrowth ( Figs. 2A and D) . Control immunocytochemical reactions showed the absence of non-specific staining when the primary anti-FGF-4 antibody was either substituted with normal goat IgG or omitted from the protocol (data not shown). Autoimmunofluorescence was also not detectable (data not shown). Compared to control embryos, no difference in FGF-4 immunofluorescence intensity was detected when blastocysts were examined at the end of the 24-h incubation period in high d-glucose (Fig. 2C) . When embryos were observed after spreading over the fibronectin-coated culture substrate, the FGF-4 immunofluorescence intensity detected in the ICM of blastocysts pre-exposed to high d-glucose decreased by 32 % (p £ 0.01) (Fig. 2F) . The FGF-4 protein expression in blastocysts pre-exposed to a combination of 22 mmol/l l-glucose and 6 mmol/l d-glucose during the first incubation period was similar to that found in control trophoblast outgrowths.
To further probe the possible cause and effect relationship between the decreased expression of FGF-4 in the ICM and the excess spreading of the trophoblast layer following exposure to high d-glucose, blastocysts were cultured in either 6 mmol/l or 28 mmol/l d-glucose in the presence or absence of 2.5 ng/ml of human recombinant FGF-4 for 24 h and then tested for their ability to spread over a fibronectin-coated culture surface. No difference was found between the four culture groups with respect to the percentage of blastocysts that were forming trophoblast outgrowths (p = 0.80) (Fig. 3A) . In confirmation of previous data (Fig. 1E) , pre-exposing blastocysts to high d-glucose for 24 h resulted in a marked increase in the surface of their trophoblast outgrowth (p £ 0.05) (Fig. 3B) . Addition of recombinant FGF-4 during the high d-glucose treatment period resulted in the normalization of this growth parameter. Trophoblast outgrowth spreading was not modified by the addition of recombinant FGF-4 to the control culture medium.
No difference was observed between the four culture groups with respect to the mean number of trophoblasts per outgrowth (p = 0.51) (Fig. 3C) . Further examination, however, showed that the average nuclear area of the trophoblast cells increased by 27 % in trophoblast outgrowths derived from blastocysts that had been pre-exposed to high d-glucose (p £ 0.01) (Fig. 3D) . A higher proportion of trophoblasts were identified as giant cells at the periphery of these embryos (p = 0.09) (Fig. 3E) . Both trophoblast outgrowth surface and trophoblast nuclear area values were corrected by the addition of recombinant FGF-4 to 28 mmol/l d-glucose during the 24-h incubation period. Recombinant FGF-4 had no effect on these two parameters when added to the control culture medium. No difference was detected between the four culture groups with respect to the frequency of trophoblasts showing signs of karyorhexis (p = 0.32) (Fig. 3F) . Other experiments showed that pre-exposure of blastocysts to a combination of 22 mmol/l l-glucose and 6 mmol/l d-glucose during the first incubation period had no influence on the different growth parameters tested above (number of trophoblasts per embryo, average nuclear area, index of giant cells and karyorhexis index, data not shown). 
Discussion
Our data show that exposing mouse blastocysts to high d-glucose in vitro for a short time results in the formation of abnormally large trophoblast outgrowths. This alteration was associated with an increase in the average surface area of trophoblast nuclei, suggesting an increased proportion of trophoblasts presenting as giant cells. Thus, a disruption of the intra-embryonic mechanism that controls the transformation of the trophoblastic cells could be induced by high d-glucose.
Our findings correlate with previous reports showing that blastocysts collected from diabetic rats tended to form larger TE layers than was the case in control embryos [5] and contained a higher proportion of giant trophoblasts when allowed to spread onto a culture substrate [14] . Recent experiments have also shown that exposing mouse ectoplacental cone cells to high d-glucose stimulated these explants into excessive outgrowth [24] . In addition, abnormally high numbers of giant trophoblasts have been observed in utero-placental units of diabetic rats [25, R. Lea and S. Pampfer, unpublished data].
Not much is known about the cellular and molecular mechanism(s) responsible for controlling the development of trophoblast cells at the onset of implantation. Previous experiments suggest that important regulatory events operate at the interface between ICM cells and polar TE cells (those TE cells in direct contact with the ICM) to prevent a core group of these pre-trophoblastic cells from being transformed into giant cells [26, 27] . Maintenance of a sufficient population of diploid trophoblasts is necessary for full placental development beyond the first peri-im- plantation wave of giant cell transformation. Potent regulatory peptides such as those belonging to the FGF family are thought to be actively involved in the control of TE differentiation by ICM cells [9] . One of these factors, FGF-4, has been shown to be specifically expressed in the ICM cells of mouse blastocysts [10, 22, 28] , to stimulate the proliferation of mouse TE cells [29] and to repress their transformation and differentiation into giant trophoblasts [11] . In pre-implantation mouse blastocysts, the phagocytic activity of mural TE, a giant cell differentiation marker, was inhibited by the addition of FGF-4 [30] . Mouse embryos in which the fgf-4 gene was deleted could only form giant trophoblasts and aborted shortly after implantation [31] . Blastocysts, deficient for the transcription factor Oct-4, are characterized by very low expression levels of endogenous FGF-4 in their ICM and displayed an identical phenotype and could, furthermore, be rescued by the addition of exogenous FGF-4 [32] . Our experiments showed that, in contrast to control blastocysts, those embryos pre-incubated for 24 h in high concentrations of d-glucose contained less FGF-4 protein in the ICM cells after the blastocysts had been transferred for another 48 h into a second culture medium for in vitro implantation. Because the ICM core forms a very compact cell mass that makes the counting of these cells very difficult, it is not clear whether high d-glucose caused the reduction in FGF-4 by reducing the number of FGF-4-producing cells or by impacting on the regulation of FGF-4 protein synthesis. Our data indicate the first possibility, however, because the percentage of ICM cells showing signs of apoptosis increased following exposure to high d-glucose. TE was more resistant to cell death, even after the second incubation period.
In our experiments, the addition of recombinant FGF-4 to high d-glucose prevented the subsequent formation of an abnormally large trophoblast outgrowth and normalized the mean nuclear area of the trophoblast cells. How exogenous FGF-4 corrects the influence of high d-glucose during the first incubation period is not known. The addition of FGF-4 could restore enough TE cells to a proliferative mode and delay their subsequent transformation. The absence of an effect of FGF-4 on control blastocysts is also intriguing. Unpublished experiments have shown that adding recombinant FGF-4 at the same concentration but during the second incubation period, significantly reduced trophoblast development (data not shown), confirming that there is a negative relationship between FGF-4 and giant cell transformation. Further work is clearly needed to understand how FGF-4 regulates trophoblast differentiation in both normal and pathological situations. What is known, however, is that FGF-4 requires the expression of a receptor by TE cells, probably FGFR2 [33, 34] , and the combination with some still unknown factor(s) in the serum, to act properly [11, 30] .
In conclusion, our data indicate that exposure to high d-glucose in vitro induces a decrease in the expression of FGF-4 protein in the ICM cell lineage of mouse blastocysts. The FGF-4 deficiency in turn disrupts the FGF-4-based negative regulatory effect that ICM cells exert over the differentiation of TE cells into giant trophoblasts. These observations could help explain some of the ultrastructural anomalies detected in the placenta of diabetic pregnancies.
